Conservative think tank focused on urban policy, economics, and public policy research.
A new report explores the potential shift in employer-sponsored health insurance, examining factors that could lead companies to reconsider their role in providing coverage to employees.
This amicus brief discusses the legal implications of the case Relentless v. Department of Commerce, examining issues related to government transparency and regulatory authority.
Québec's push for green energy is inadvertently increasing fossil fuel reliance in New York, highlighting the complexities of regional energy policies and their unintended consequences.
The article argues that schools should focus on education rather than serving as mental health facilities, emphasizing the need for clear boundaries between academic and psychological support.
The article critiques Zohran Mamdani's policies and decisions, arguing that his lack of understanding could lead to detrimental consequences for New York's future.
The article critiques American universities, particularly Harvard, for prioritizing activism over academic excellence, suggesting that this trend may hinder their global competitiveness, especially against China.
The article critiques Elon Musk's views on AI's impact on retirement, emphasizing the importance of personal savings and financial planning despite advancements in technology.
The article examines how the latest dietary guidelines highlight potential issues with state-run grocery stores, raising concerns about government influence on food choices and public health.
The article explores how historic preservation efforts in New York City can drive up housing costs, highlighting the tension between maintaining heritage and addressing housing shortages.
The article explores the pervasive issue of violence in urban environments, urging a shift from complacency to proactive solutions that address the root causes and enhance community safety.
The article argues against the skepticism surrounding technology, highlighting its potential to drive innovation and improve lives, urging a more optimistic perspective on tech advancements.
The article discusses the Manhattan Institute's amicus brief in the case of Janssen Pharmaceuticals v. Kennedy, highlighting key legal arguments and implications for pharmaceutical liability.